# MBA Early Feasibility Study

> **NCT07564375** · NA · NOT_YET_RECRUITING · sponsor: **W.L.Gore & Associates** · enrollment: 20 (estimated)

## Conditions studied

- Thoracic Aortic Aneurysm
- Penetrating Aortic Ulcers (PAUs)
- Thoracic Aortic Dissection
- Pseudoaneurysm

## Interventions

- **DEVICE:** GORE® Multibranch Arch Endoprosthesis
- **DEVICE:** GORE® Ascending Stent Graft

## Key facts

- **NCT ID:** NCT07564375
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2029-11
- **Final completion:** 2034-11
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07564375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07564375, "MBA Early Feasibility Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07564375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*